Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron vs Solifenacin in Women with OAB
NCT04023253Phase 3Unknown
- Sponsor
- Far Eastern Memorial Hospital
- Start
- Aug 2019
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mirabegron in overactive bladder syndrome (OAB), sponsored by Far Eastern Memorial Hospital. Status: unknown.
02
Drugs
mirabegron
03
Conditions
overactive bladder syndrome (OAB)
Beyond the preview
Go deeper on NCT04023253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04023253.